Thompson Davis & Co’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$110K Hold
1,199
0.24% 98
2018
Q2
$118K Sell
1,199
-126
-10% -$14.1K 0.28% 85
2018
Q1
$148K Hold
1,325
0.39% 67
2017
Q4
$136K Sell
1,325
-491
-27% -$48.9K 0.32% 79
2017
Q3
$171K Sell
1,816
-1,242
-41% -$98K 0.3% 81
2017
Q2
$238K Sell
3,058
-2,189
-42% -$164K 0.38% 67
2017
Q1
$420K Sell
5,247
-250
-5% -$19.9K 0.6% 42
2016
Q4
$433K Sell
5,497
-91
-2% -$7.07K 0.72% 24
2016
Q3
$436K Buy
5,588
+2
+0% +$145 0.77% 23
2016
Q2
$384K Sell
5,586
-678
-11% -$46.8K 0.61% 27
2016
Q1
$447K Sell
6,264
-510
-8% -$32K 0.67% 27
2015
Q4
$421K Hold
6,774
0.59% 28
2015
Q3
$384K Sell
6,774
-30
-0.4% -$1.59K 0.54% 41
2015
Q2
$365K Sell
6,804
-34
-0.5% -$1.65K 0.42% 45
2015
Q1
$325K Buy
6,838
+25
+0.4% +$1.11K 0.39% 51
2014
Q4
$295K Sell
6,813
-3,257
-32% -$133K 0.34% 60
2014
Q3
$346K Sell
10,070
-3,329
-25% -$118K 0.45% 46
2014
Q2
$491K Sell
13,399
-1,625
-11% -$55.1K 0.71% 30
2014
Q1
$507K Sell
15,024
-1,625
-10% -$53.6K 0.84% 24
2013
Q4
$565K Buy
+16,649
New +$577K 0.85% 24

Other funds holding CMD

Thompson Davis & Co's CMD Position: Q3 2018 in Review

Thompson Davis & Co held its Cantel Medical Corporation (CMD) position steady in Q3 2018 at 1,199 shares worth $110K. The position accounts for 0.24% of the portfolio, ranked #98.

Thompson Davis & Co first reported a position in CMD in Q4 2013 and has held it in 20 quarters since. The position peaked at $565K in Q4 2013. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Thompson Davis & Co held 1,199 shares of Cantel Medical Corporation worth $110K as of Q3 2018.
  • Thompson Davis & Co left its Cantel Medical Corporation share count unchanged in Q3 2018.
  • Cantel Medical Corporation made up 0.24% of Thompson Davis & Co's portfolio in Q3 2018, its #98 holding.
  • Thompson Davis & Co first reported a position in Cantel Medical Corporation in Q4 2013 and has held it in 20 quarters since.
  • Thompson Davis & Co's Cantel Medical Corporation position peaked at $565K in Q4 2013.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.